$LIF

COGHLAN JOHN PHILIP sold $167K of LIF (indirect holdings)

COGHLAN JOHN PHILIP sold 3,796 indirectly-held shares of Life360, Inc. (LIF) at $43.95 ($0.17M total) on 2026-06-01 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · COGHLAN JOHN PHILIP
Published Jun 2, 2026, 9:48 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 2, 2026, 9:50 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$LIF
Neutral
medium confidence
Mentioned
$LIF
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$LIFNeutralLow
01

Why it matters

The disclosure updates the insider activity record but does not provide new company fundamentals (no guidance, financial results, or deal terms).

02

Market read

Traders may treat this as a minor sentiment datapoint rather than a standalone catalyst.

03

What to watch

Consider whether the sale size is unusual relative to prior director transactions and whether there are concurrent insider buys/sales not captured here.

Relevance 6/10Novelty 4/10Timing: Filed today; transaction dated 2026-06-01

Background

SEC Form 4 reports insider transactions; this one is an open-market sale by a director with a pre-arranged Rule 10b5-1 plan.

Company-level read

Ticker impact

$LIFNeutralMedium confidence
Context

Life360 director Coghlan sold 3,796 shares in an open-market transaction disclosed on SEC Form 4 at ~$43.95/share.

Expected impact

Likely limited immediate price impact; any effect should be short-lived unless follow-on selling or other news emerges.

Evidence & confidence

The filing is an ownership-change disclosure (not earnings/M&A/regulatory), and it explicitly references a pre-arranged 10b5-1 plan, which often reduces interpretive weight.

Market effects

Minimal—single-company insider transaction with no stated operational or regulatory catalyst.

None indicated.

None indicated.

Counterpoint

Even with 10b5-1, repeated or sizable director sales can reflect private risk concerns; monitor for clustering of similar filings.

Key entities

  • Life360, Inc.

    Subject of the Form 4 insider sale disclosure.

  • COGHLAN JOHN PHILIP

    Director who sold 3,796 shares on 2026-06-01 under a 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$LIFMed

Why Life360 Stock Is Plunging Lower This Week

Life360 (NASDAQ: LIF) shares fell about 18% after Q2 results despite beating analyst expectations. The company reported Q2 sales up 38% and MAUs up 16% to over 100 million, with advertising revenue quadrupling to 14% of sales. Management did not raise full-year guidance, and the stock trades around 45x free cash flow.

$LIFMedAI 8/10

Life360 (LIF) Q2 2026 Earnings Call Transcript

Life360 (LIF) reported Q2 2026 revenue of $159.0 million, up 38% year over year, driven by $115.6 million subscription revenue (+31%) and $22.0 million advertising revenue (+315%) after Nativo integration. MAU rose to 102.4 million (+16%). Adjusted EBITDA was $31.1 million (+53%). Full-year subscription guidance raised to $475-$480 million; revenue $650-$685 million.

$LIFMed

Why Life360 Stock Is Crashing Today

Life360 (NASDAQ: LIF) shares fell 25.7% Tuesday after the company reported Q2 results. Q2 revenue rose 38% to $159 million, while GAAP EPS fell to $0.06. Management kept full-year revenue and profit guidance unchanged, adjusting subscription and retail hardware targets. CFO Russell Burke said AI-native transition should drive operating leverage starting in 2027.

$LIFMed

Why Life360 Stock Is Plunging Lower This Week

Life360 (LIF) shares fell about 18% for the week after the company reported Q2 earnings. According to Life360, Q2 revenue rose 38%, MAUs grew 16% to over 100 million, and adjusted EBITDA increased 53%. The stock dropped despite beating analyst expectations because management did not raise full-year guidance.

$LIFMedAI 8/10

Life360 Q2 Results: Revenue rises 38% YoY, but stock falls 25%

Life360 Inc. (NASDAQ: LIF) shares fell about 25% to $50.20 after Q2 results beat estimates but the company kept fiscal 2026 revenue guidance at $650 million to $685 million, below the $670.24 million analyst midpoint. Q2 EPS was $0.06 vs $0.01; revenue was $158.96 million vs $156.39 million. Advertising revenue hit $22 million.